Price history
Price history loads when this section approaches view.
TradingView data is temporarily unavailable
The rest of this research page remains available.
View this listing on TradingView ↗Company research
Johnson & Johnson
JNJ
- Current Tracked Holders
- 1
- One-Year Insider Activity
-
Purchases 1 $257,688Sales 35 $145.9M
Price history
Quarter-End Change Analysis
No published quarterly analysis yet
Reviewed research will appear here when it is published.
Current reported holders
| Portfolio Manager | Recent activity | Shares | Value | Portfolio |
|---|---|---|---|---|
| Thomas RussoGardner Russo & Quinn LLC | JNJAdded | 1,304 | $319,000 | 0.00% |
Long-term company research
Fundamental analysis
Research pending
Fundamental research pending
Reviewed company research will appear here when available.
Insider activity
One-year insider activity
Open-market purchases and sales only.
Checked 2026-08-11
| Date | Insider | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|
| 2026-08-06 | Forminard ElizabethEVP, Chief Legal Officer | Sale | 9,344 | $258 | $2.4M | SEC ↗ |
| 2026-08-06 | Forminard ElizabethEVP, Chief Legal Officer | Sale | 6,574 | $256 | $1.7M | SEC ↗ |
| 2026-08-05 | Duato JoaquinDirector, CEO and Chairman of the Board | Sale | 41,957 | $258 | $10.8M | SEC ↗ |
| 2026-08-05 | Duato JoaquinDirector, CEO and Chairman of the Board | Sale | 6,523 | $259 | $1.7M | SEC ↗ |
| 2026-07-20 | Broadhurst VanessaEVP, Global Corp Affairs | Sale | 23,054 | $251 | $5.8M | SEC ↗ |
| 2026-06-11 | Wengel Kathryn EEVP, Chief TO and Risk Officer | Sale | 10,000 | $241 | $2.4M | SEC ↗ |
| 2026-02-27 | Decker Robert JVP Corporate Controller | Sale | 4,075 | $248 | $1.0M | SEC ↗ |
| 2026-02-20 | Schmid TimothyEVP, WW Chair, MedTech | Sale | 1,322 | $246 | $324,763 | SEC ↗ |
| 2026-02-18 | Schmid TimothyEVP, WW Chair, MedTech | Sale | 13,625 | $244 | $3.3M | SEC ↗ |
| 2026-02-18 | Schmid TimothyEVP, WW Chair, MedTech | Sale | 8,998 | $245 | $2.2M | SEC ↗ |
| 2026-02-17 | Swanson James D.EVP, CIO | Sale | 20,521 | $243 | $5.0M | SEC ↗ |
| 2026-02-17 | Wolk Joseph JExec VP, CFO | Sale | 19,241 | $243 | $4.7M | SEC ↗ |
| 2026-02-17 | Wolk Joseph JExec VP, CFO | Sale | 12,066 | $243 | $2.9M | SEC ↗ |
| 2026-02-17 | Wolk Joseph JExec VP, CFO | Sale | 33,386 | $243 | $8.1M | SEC ↗ |
| 2026-02-17 | Wolk Joseph JExec VP, CFO | Sale | 24,961 | $243 | $6.1M | SEC ↗ |
| 2026-02-17 | REED JOHN CEVP, Innovative Medicine, R&D | Sale | 21,721 | $243 | $5.3M | SEC ↗ |
| 2026-02-17 | REED JOHN CEVP, Innovative Medicine, R&D | Sale | 29,927 | $243 | $7.3M | SEC ↗ |
| 2026-02-17 | REED JOHN CEVP, Innovative Medicine, R&D | Sale | 2,283 | $243 | $554,769 | SEC ↗ |
| 2026-02-17 | Broadhurst VanessaEVP, Global Corp Affairs | Sale | 6,197 | $243 | $1.5M | SEC ↗ |
| 2026-02-13 | Swanson James D.EVP, CIO | Sale | 19,368 | $244 | $4.7M | SEC ↗ |
Older transactions
| Date | Insider | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|
| 2026-02-13 | Swanson James D.EVP, CIO | Sale | 22,191 | $244 | $5.4M | SEC ↗ |
| 2026-01-26 | Duato JoaquinDirector, CEO and Chairman of the Board | Sale | 51,218 | $221 | $11.3M | SEC ↗ |
| 2026-01-26 | Duato JoaquinDirector, CEO and Chairman of the Board | Sale | 48,782 | $221 | $10.8M | SEC ↗ |
| 2025-11-26 | JOHNSON & JOHNSON; Johnson & Johnson Innovation - JJDC, Inc. | Sale | 6,337 | $10 | $63,560 | SEC ↗ |
| 2025-11-26 | JOHNSON & JOHNSON; Johnson & Johnson Innovation - JJDC, Inc. | Sale | 6,337 | $10 | $63,560 | SEC ↗ |
| 2025-11-26 | MORIKIS JOHN GDirector | Purchase | 1,250 | $206 | $257,688 | SEC ↗ |
| 2025-11-25 | JOHNSON & JOHNSON; Johnson & Johnson Innovation - JJDC, Inc. | Sale | 16,000 | $10 | $160,480 | SEC ↗ |
| 2025-11-24 | JOHNSON & JOHNSON; Johnson & Johnson Innovation - JJDC, Inc. | Sale | 2,200 | $10 | $22,132 | SEC ↗ |
| 2025-11-21 | JOHNSON & JOHNSON; Johnson & Johnson Innovation - JJDC, Inc. | Sale | 500 | $10 | $5,000 | SEC ↗ |
| 2025-11-12 | JOHNSON & JOHNSON; Johnson & Johnson Innovation - JJDC, Inc. | Sale | 1,000 | $10 | $10,000 | SEC ↗ |
| 2025-11-07 | JOHNSON & JOHNSON; Johnson & Johnson Innovation - JJDC, Inc. | Sale | 200 | $10 | $2,000 | SEC ↗ |
| 2025-11-06 | JOHNSON & JOHNSON; Johnson & Johnson Innovation - JJDC, Inc. | Sale | 52,332 | $10 | $534,310 | SEC ↗ |
| 2025-10-17 | REED JOHN CEVP, Innovative Medicine, R&D | Sale | 21,721 | $193 | $4.2M | SEC ↗ |
| 2025-09-04 | Taubert Jennifer LEVP, WWC. Innovative Medicine | Sale | 56,471 | $178 | $10.0M | SEC ↗ |
| 2025-08-22 | Duato JoaquinDirector, CEO and Chairman of the Board | Sale | 125,824 | $179 | $22.5M | SEC ↗ |
| 2025-08-15 | Wolk Joseph JExec VP, CFO | Sale | 16,820 | $177 | $3.0M | SEC ↗ |